Cart
sales@molnova.com
Phaeocaulisin E
CAS No. 1443040-31-0
Phaeocaulisin E( ——— )
Catalog No. M38219 CAS No. 1443040-31-0
Phaeocaulisin E (Compound 5) is a guaiane-type sesquiterpene that inhibits LPS HY-induced NO production in RAW 264.7 macrophages with an IC50 of 10.3 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhaeocaulisin E
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhaeocaulisin E (Compound 5) is a guaiane-type sesquiterpene that inhibits LPS HY-induced NO production in RAW 264.7 macrophages with an IC50 of 10.3 μM.
-
DescriptionPhaeocaulisin E (Compound 5) is a guaiane-type sesquiterpene that inhibits LPS HY-induced NO production in RAW 264.7 macrophages with an IC50 of 10.3 μM.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1443040-31-0
-
Formula Weight252.35
-
Molecular FormulaC15H24O3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu Y, et al. Guaiane-type sesquiterpenes from Curcuma phaeocaulis and their inhibitory effects on nitric oxide production. J Nat Prod. 2013 Jun 28;76(6):1150-6.?
molnova catalog
related products
-
PKR-IN-C16
PKR-IN-C16 is a specific protein kinase (PKR) inhibitor.?PKR-IN-C16 is able to inhibit the autophosphorylation of PKR and unlock the translation blockade induced by PKR in primary neuronal cultures.PKR-IN-C16 binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.?
-
Pomalidomide-C2-acid
Pomalidomide-C2-acid is a PROTAC building block.
-
Schnurri-3 inhibitor...
Schnurri-3 inhibitor-1, a potent inhibitor of schnurri-3, is an essential regulator of bone formation in adults that can be used in osteoporosis research. Schnurri-3 inhibitor-1 can inhibit Shn3 with EF1alpha promoter in osteoblast cell line Shn3FFL (AC50 = 2.09 μM) .
